MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Dopamine Dysregulation in Parkinson’s Disease and Substance Use: Therapeutic Use and Compulsive Behaviors Thin Line

    J. Hall, R. Islam, D. Nolasco, B. Carr (GAINESVILLE, USA)

    Objective: Parkinson's Disease (PD) inherently disrupts dopaminergic transmission, primarily within the nigrostriatal pathway, necessitating dopaminergic therapies. However, these therapies can lead to Dopamine Dysregulation Syndrome…
  • 2024 International Congress

    Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database

    W. Zhang, S. Shuvo, A. Gabriel, A. Yaldo, G. Agreda, C. Goetzsche, T. Machewitz, M. Nadimi, J. Lott (Whippany, USA)

    Objective: To describe sociodemographic characteristics and healthcare resource utilization (HRU) among Parkinson’s disease (PD) patients across US health insurance plans. Background: PD affects nearly 1…
  • 2024 International Congress

    Gender Differences in Physical Activity in Parkinson’s Disease

    G. Vitek, M. Fullard (Aurora, USA)

    Objective: Examine gender differences in physical activity in different stages of Parkinson’s disease (PD). Background: Physical activity has been linked to slower progression and improvement…
  • 2024 International Congress

    Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

    C A. Hurtado-Gonzalez, J F. Ayala-Rico, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, D A. Reyes-Torres, P A. Gutiérrez-Lenis, L M. Saldarriaga, C O. Moreno (Cali, Colombia)

    Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…
  • 2024 International Congress

    An Analysis of Baseline Measures from a Diverse Parkinson’s Disease Interdisciplinary Clinic

    V. Armengol, M. Feldman, M. Sarno, S. Marmol, A. Alfonso, G. Dumenigo, M. Garcia-Casals, S. Munzesheimer, A. Otto, TW. Siu, D. Yacinthe, D. Shpiner (Miami, USA)

    Objective: To analyze differences in baseline characteristics of patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: The University of Miami…
  • 2024 International Congress

    Cross-cultural adaptation to Argentine Spanish and validation of the High Level Mobility Assessment Tool in individuals with Parkinson’s disease

    G. Peker, J. Lopez Arrubla, J. Ortiz, N. Alva, M. Andreu, G. Williams, E. Gatto (Buenos Aires, Argentina)

    Objective: To translate and adapt the High-Level Mobility Assessment Tool (HiMAT) into Argentine Spanish and evaluate its psychometric properties in individuals with Parkinson's disease (PD).…
  • 2024 International Congress

    Developing a Virtual Brick-Building Group for Veterans with Movement Disorders

    J. Kaplan, C. Kausek, J. Lehosit (Richmond, USA)

    Objective: To improve quality of life for Veterans with movement disorders by creating a virtual group using building bricks Background: Parkinson’s disease (PD) may cause…
  • 2024 International Congress

    “Quality of Life of Caregivers Living with a Movement Disorder. A Comprehensive Approach.”

    R. Baños-Betancourt, A. Domínguez García, A. Cervantes-Arriaga, M. Rodríguez-Violante, A. Hernández-Medrano, W. Moguel-Cardín, G. Rivera-Monroy, K. Velázquez-Román, C. álvarez-Hernández, A. Guerra-Anzaldo, D. Romero-Terán, K. SáNCHEZ-RAMíREZ., S. Arechavala-Lopez, N. Moreno-Aldama, J. Delgado-Uriarte, E. Correa-Medina (Mexico City, Mexico)

    Objective: Exploring self-perceived health, quality of life, economic factors, and social-work aspect of caregivers of patients living with some type of movement disorder. Background: Caregivers…
  • 2024 International Congress

    Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): PDQ-39 Results from a Phase 3 Randomized Active-Controlled Study

    H. Sarva, M. Tagliati, W. Poewe, F. Stocchi, O. Rascol, T. Yardeni, N. Lopes, J. Pereira, A. Espay (New York, USA)

    Objective: Evaluate quality of life (QoL) data from the Phase 3 randomized, active-controlled BouNDless study. Background: Pivotal data from the BouNDless study (NCT04006210) showed that…
  • 2024 International Congress

    Gait Digital Outcomes Exploration from Continuous Real-World Recordings in Parkinson’s Disease

    M. Michaud, G. Parinello, E. Kluczka, C. Cluzeau, M-L. Brechemier, F. Bompaire, C. Tafani, M. Sallansonnet-Froment, T. Gidaro, L. Oudre, D. Ricard (Gif-Sur-Yvette, France)

    Objective: To measure how people with Parkinson's disease (PD) feel, function, and survive, derived from continuous recordings with a wearable ankle inertial device in a real-world…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley